• Register
  • Login

Iranian Journal of Pharmaceutical Sciences

  • Home
  • Journal Info
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Indexing & Abstracting
    • Privacy Statement
    • Contact us
  • Issues
    • Current
    • Archives
  • New Submissions
  • Author Guidelines
  • Policies & Process
    • Peer Review
    • Publication Ethics
    • Open Access Policy
    • Plagiarism
    • Retraction Policies
    • Archiving
  • Ethical Considration
Advanced Search
  1. Home
  2. Archives
  3. Vol. 6 No. 1 (2010): IJPS_Volume 6_Issue 1 (2010)
  4. Research/Original Articles

Vol. 6 No. 1 (2010)

January 2010

Intravenous Methylprednisolone, a Possible Cause of the Atrial Fibrillation Atrial fibrillation by methylprednisolon

  • Afsaneh Vazin
  • Gholamreza Rouzitalab
  • Mohammad Firoozifar
  • Farid Zand

Iranian Journal of Pharmaceutical Sciences, Vol. 6 No. 1 (2010), 15 January 2010 , Page 13-18
https://doi.org/10.22037/ijps.v6.41233

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

We are presenting a case illustrating atrial fibrillation (AF) following the use of methylprednisolone in a patient with pelvic and femur fracture. A48- year- old man with no significant past medical history, was admitted to the emergency department after injury in a car accident. He suffered a multiple bone fracture with chief complaints of pain and shortness of breath. He was transferred to the ICU. To prevent
fat embolism syndrome, he was treated with methylprednisolone 500 mg every 6 h. About 4 h after the second dose, his normal sinus rhythm changed to a sinus tachycardia and then to AF. The methylprednisolone therapy was discontinued. After about 8 h of methylprednisolone discontinuation, the patient's normal sinus rhythm returned. Corticosteroids have been utilized for prevention and treatment of fat embolism syndrome, although there is uncertainty about their effectiveness. Cardiac dysrhythmias have been reported following the use of methylprednisolone. One possible mechanism of methylprednisolone induced AF is the direct effect on cell membrane, resulting in potassium efflux, which in turn, may initiate cardiac dysrhythmias. Previous methylprednisolone-associated AF case reports suggest a higher chance of AF occurrence with higher dose of methylprednisolone. Corticosteroids should be used with caution, especially when high doses are indicated and in patients with high risk for arrhythmias.

Keywords:
  • Arrhythmia
  • Atrial fibrillation
  • Fat embolism
  • Methylprednisolone
  • IJPS_Volume 6_Issue 1_Pages 13-18

How to Cite

Afsaneh Vazin, Gholamreza Rouzitalab, Mohammad Firoozifar, & Farid Zand. (2010). Intravenous Methylprednisolone, a Possible Cause of the Atrial Fibrillation: Atrial fibrillation by methylprednisolon. Iranian Journal of Pharmaceutical Sciences, 6(1), 13–18. https://doi.org/10.22037/ijps.v6.41233
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

[1] Lindeque BG, Schoeman HS, Dommisse GF, Boeyens MC, Vlok AL. Fat embolism and the aat embolism syndrome. J Bone Joint Surg 1987; 69-B: 128-31.
[2] Stein PD, Yaekoub AY, Matta F, Kleerekoper M. Fat embolism syndrome. Am J Med Sci 2008; 336: 472-7.
[3] Kirkland L. Fat embolism (article). Available at http://www.emedicine.com/med/topic652.htm
[4] Talbot M, Schemitsch EH. Fat embolism syndrome: History, definition, epidemiology. Injury 2006; 37 Suppl 4: S3-7.
[5] Richards R. Fat embolism syndrome. Can J Surg 1997; 40: 334-9.
[6] Habashi N, Andrews P, Scalea T .Therapeutic aspects of fat embolism syndrome. Injury 2006; 37 Suppl 4: S68-73.
[7] Ueda N, Yoshikawa T, Chihara M, Kawaguchi S, Niinomi Y, Yasaki T. Atrial fibrillation following methylprednisolone pulse therapy. Pediatr Nephrol 1988; 2: 29-31.
[8] Aslam AK, Vasavada BC, Sacchi TJ, Khan IA. Atrial fibrillation associated with systemic lupus erythematosus and use of methylprednisolone. Am J Ther 2001; 8: 303-5.
[9] McLuckie AE, Savage RW. Atrial fibrillation following pulse methylprednisolone therapy in an adult. Chest 1993; 104: 622-3.
[10] Moretti R, Torre P, Antonello RM, Zorzon M, Cazzato G. Recurrent atrial fibrillation associated with pulse administration of high doses of methylprednysolone: Apossible prophylactic treatment. Eur J Neurol 2000; 7:130.
[11] Taviloglu K, Yanar H. Fat embolism syndrome. Surg Today 2007; 37: 5-8.
[12] Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
[13] van der Hooft CS, Heeringa J, Brusselle GG, Hofman A, Witteman JC, Kingma JH, Sturkenboom MC, Stricker BH. Corticosteroids and the risk of atrial fibrillation. Arch Intern Med 2006; 166: 1016-20.
[14] Huerta C, Lanes SF, García Rodríguez LA. Respiratory medications and the risk of cardiac arrhythmias. Epidemiology 2005; 16: 360-6.
[15] Fujimoto S, Kondoh H, Yamamoto Y, Hisanaga S, Tanaka K. Holter electrocardiogram monitoring in nephrotic patients during methylprednisolone pulse therapy. Am J Nephrol 1990; 10: 231-6.
[16] Ozen S, Tokgozoglu L, Saatci U. Are late potentials operative in arrhythmias following methylprednisolone pulse therapy. Int J Cardiol 1992; 36: 234-5.
[17] Freedman MD, Schocket AL, Chapel N, Gerber JG.. Anaphylaxis after intravenous methylprednisolone administration. JAMA 1981; 245: 607-8.
  • Abstract Viewed: 304 times
  • IJPS_Volume 6_Issue 1_Pages 13-18 Downloaded: 313 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems

Information

  • For Readers
  • For Authors
  • For Librarians
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

Creative Commons License
This journal (and its contents) is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Print ISSN: 1735-2444

Online ISSN: 2252-0457

Powered by OJSPlus